002720.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:30):

Stats
Dzisiejszy wolumen	127 431
Średni wolumen	1.80M
Kapitalizacja rynkowa	100.04B
EPS	KRW0 ( 2023-09-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW8.43 (0.17%)

Wolumen Korelacja

Długi: -0.25 (neutral)

Krótki: -1.00 (very strong negative)

Signal:(44.929) Neutral

Kukje Pharma Co., Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kukje Pharma Co., Ltd. Korelacja - Waluta/Towar

-0.06
( neutral )

-0.02
( neutral )

-0.73
( moderate negative )

0.05
( neutral )

-0.43
( neutral )

0.38
( neutral )

Kukje Pharma Co., Ltd. Finanse

Annual	2023
Przychody:	KRW135.37B
Zysk brutto:	KRW66.46B (49.10 %)
EPS:	KRW-415.49

FY	2023
Przychody:	KRW135.37B
Zysk brutto:	KRW66.46B (49.10 %)
EPS:	KRW-415.49

FY	2022
Przychody:	KRW126.58B
Zysk brutto:	KRW63.25B (49.97 %)
EPS:	KRW175.58

FY	2021
Przychody:	KRW119.75B
Zysk brutto:	KRW54.47B (45.49 %)
EPS:	KRW-84.80

Financial Reports:

No articles found.

Kukje Pharma Co., Ltd.

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, and other ETC products. The company was founded in 1959 and is headquartered in Seongnam, South Korea.